First National Trust’s Gilead Sciences GILD Stock Holding History

First National Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,774	Closed	-$230K	–	386
2023 Q1	$230K	Buy	2,774 +257	+10%	+$21.3K	0.01%	337
2022 Q4	$216K	Buy	+2,517	New	+$199K	0.01%	340
2019 Q2	–	Sell	-3,119	Closed	-$203K	–	328
2019 Q1	$203K	Buy	+3,119	New	+$207K	0.02%	310
2018 Q4	–	Sell	-4,056	Closed	-$313K	–	320
2018 Q3	$313K	Sell	4,056 -3,299	-45%	-$249K	0.03%	269
2018 Q2	$521K	Sell	7,355 -4,177	-36%	-$295K	0.06%	221
2018 Q1	$870K	Sell	11,532 -2,744	-19%	-$218K	0.1%	188
2017 Q4	$1.02M	Sell	14,276 -2,389	-14%	-$181K	0.11%	179
2017 Q3	$1.35M	Sell	16,665 -2,259	-12%	-$173K	0.16%	148
2017 Q2	$1.34M	Sell	18,924 -1,814	-9%	-$121K	0.16%	146
2017 Q1	$1.41M	Sell	20,738 -4,049	-16%	-$285K	0.18%	136
2016 Q4	$1.77M	Sell	24,787 -3,774	-13%	-$281K	0.25%	108
2016 Q3	$2.26M	Buy	28,561 +1,522	+6%	+$124K	0.34%	89
2016 Q2	$2.25M	Buy	27,039 +2,086	+8%	+$185K	0.35%	85
2016 Q1	$2.29M	Sell	24,953 -699	-3%	-$63K	0.35%	84
2015 Q4	$2.6M	Buy	25,652 +7,140	+39%	+$743K	0.41%	70
2015 Q3	$1.82M	Buy	18,512 +181	+1%	+$20.1K	0.31%	91
2015 Q2	$2.15M	Buy	18,331 +4,070	+29%	+$445K	0.35%	87
2015 Q1	$1.4M	Buy	14,261 +7,749	+119%	+$787K	0.24%	117
2014 Q4	$614K	Buy	6,512 +1,053	+19%	+$109K	0.11%	166
2014 Q3	$582K	Buy	5,459 +2,430	+80%	+$238K	0.11%	169
2014 Q2	$251K	Buy	+3,029	New	+$236K	0.05%	224

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First National Trust's GILD Position: Q2 2023 in Review

First National Trust sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 2,774 shares — an estimated $230K sold.

First National Trust first reported a position in GILD in Q2 2014 and held it in 21 quarters. The position peaked at $2.6M in Q4 2015. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

First National Trust reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
First National Trust sold 2,774 Gilead Sciences shares in Q2 2023, an estimated $230K.
First National Trust first reported a position in Gilead Sciences in Q2 2014 and held it in 21 quarters.
First National Trust's Gilead Sciences position peaked at $2.6M in Q4 2015.
1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on First National Trust's 13F filing for Q2 2023, filed 1 Aug 2023.